A theranostic nanodrug synthesized with a new hyaluronan derivative with enhanced CD44 affinity, salinomycin, and indocyanine green, has been shown to significantly enhance the treatment efficacy against breast cancer in a mouse model.
Yang et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: